Skip to content

Greylock XI GP Limited Partnership

Follow

13F filer, CIK 1351699, CAMBRIDGE, MA

Greylock XI GP Limited Partnership reported $648,000 across 1 holding for the quarter ended 2014-09-30, in a 13F-HR filed 2014-10-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-14-010237

Period
2014-09-30
Reported value
$648K
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2014

Share positions as resolved from 13F-HR 0000950123-14-010237, largest first. % of portfolio is the value over $648,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AVEO PHARMACEUTICALS INCAVEO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2012Q4: restricted; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: 584,004 shares; 2014Q1: 584,004 shares; 2014Q2: 584,004 shares; 2014Q3: 584,004 shares 584,004$648K100%0

How Q3 2014 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-14-010237 base2014-10-14acceptance time not in the bulk data set